EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathways

Anzelika Rubina iD, Mihil Patel iD, Katie Nightingale, Martin Potts iD, Ceri A Fielding iD, Simon Kollnberger, Betty Lau, Kristin Ladell, Kelly L Miners iD, Jenna Nichols iD, Luis Nobre iD, Dawn Roberts iD und 10 weitere

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2303155120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Anzelika Rubina und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, United Kingdom. Hauptthemen laut MEDLINE: Cytomegalovirus, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, UKRI | Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human cytomegalovirus (HCMV) is a major human pathogen whose life-long persistence is enabled by its remarkable capacity to systematically subvert host immune defenses. In exploring the finding that HCMV infection up-regulates tumor necrosis factor receptor 2 (TNFR2), a ligand for the pro-inflammatory antiviral cytokine TNFα, we found that the underlying mechanism was due to targeting of the protease, A Disintegrin And Metalloproteinase 17 (ADAM17). ADAM17 is the prototype ‘sheddase’, a family of proteases that cleaves other membrane-bound proteins to release biologically active ectodomains into the supernatant. HCMV impaired ADAM17 surface expression through the action of two virally-encoded proteins in its U L / b’ region, UL148 and UL148D. Proteomic plasma membrane profiling of cells infected with an HCMV double-deletion mutant for UL148 and UL148D with restored ADAM17 expression, combined with ADAM17 functional blockade, showed that HCMV stabilized the surface expression of 114 proteins ( P < 0.05) in an ADAM17-dependent fashion. These included reported substrates of ADAM17 with established immunological functions such as TNFR2 and jagged1, but also numerous unreported host and viral targets, such as nectin1, UL8, and UL144. Regulation of TNFα-induced cytokine responses and NK inhibition during HCMV infection were dependent on this impairment of ADAM17. We therefore identify a viral immunoregulatory mechanism in which targeting a single sheddase enables broad regulation of multiple critical surface receptors, revealing a paradigm for viral-encoded immunomodulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytomegalovirusTumor Necrosis Factor-alphaHumansProteomeReceptors, Tumor Necrosis Factor, Type IIProteomicsMembrane ProteinsCytokinesCell MembraneMetalloproteasesADAM17 ProteinMembrane GlycoproteinsViral ProteinsViral Fusion Proteins

Stichwörter der Autor:innen

ADAM17Human cytomegalovirusImmune regulation

Substanzen

Tumor Necrosis Factor-alphaProteomeReceptors, Tumor Necrosis Factor, Type IIMembrane ProteinsCytokinesMetalloproteasesADAM17 ProteinMembrane GlycoproteinsViral ProteinsUL144 ORF protein, Human herpesvirus 5

Autor:innen und Institutionen

  • Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, United Kingdom.
  • Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom.
  • Department of Medicine, University of Cambridge, Cambridge CB2 0XY, United Kingdom.
  • Centre for Virus Research, University of Glasgow, Glasgow G12 8TA, United Kingdom.

ORCID-Profile: Anzelika Rubina, Mihil Patel, Martin Potts, Ceri A Fielding, Kelly L Miners, Jenna Nichols, Luis Nobre, Dawn Roberts, Virginia-Maria Vlahava, Andrew J Davison, Gavin W G Wilkinson, Michael P Weekes, Richard J Stanton, Eddie C Y Wang

Förderung

  • Medical Research Council
  • Wellcome Trust
  • UKRI | Medical Research Council

Zitieren

APA

Rubina, A., Patel, M., Nightingale, K., Potts, M., Fielding, C. A., Kollnberger, S., Lau, B., Ladell, K., Miners, K. L., Nichols, J., Nobre, L., Roberts, D., Trinca, T. M., Twohig, J. P., Vlahava, V. M., Davison, A. J., Price, D. A., Tomasec, P., Wilkinson, G. W. G., …, & Wang, E. C. Y. (2023). ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathways. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2303155120

Vancouver

Rubina A, Patel M, Nightingale K, Potts M, Fielding CA, Kollnberger S, et al. ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathways. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2303155120

BibTeX
@article{Rubina2023,
  author = {Rubina, Anzelika and Patel, Mihil and Nightingale, Katie and Potts, Martin and Fielding, Ceri A and Kollnberger, Simon and Lau, Betty and Ladell, Kristin and Miners, Kelly L and Nichols, Jenna and Nobre, Luis and Roberts, Dawn and Trinca, Terrence M and Twohig, Jason P and Vlahava, Virginia-Maria and Davison, Andrew J and Price, David A and Tomasec, Peter and Wilkinson, Gavin W G and Weekes, Michael P and Stanton, Richard J and Wang, Eddie C Y},
  title = {ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathways},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2303155120}
}
Kostenlos starten →